All Stories

  1. A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway

    Article • International Journal of Nanomedicine, December 2019, Taylor & Francis

    Ba Hieu Tran

  2. ZYZ-803, a novel hydrogen sulfide-nitric oxide conjugated donor, promotes angiogenesis via cross-talk between STAT3 and CaMKII

    Article • Acta Pharmacologica Sinica, July 2019, Springer Science + Business Media

    Ba Hieu Tran

  3. ZYZ-803 Mitigates Endoplasmic Reticulum Stress-Related Necroptosis after Acute Myocardial Infarction through Downregulating the RIP3-CaMKII Signaling Pathway

    Article • Oxidative Medicine and Cellular Longevity, June 2019, Hindawi Publishing Corporation

    Ba Hieu Tran

  4. ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Ba Hieu Tran

  5. Novel protective effects of pulsed electromagnetic field ischemia/reperfusion injury rats

    Article • Bioscience Reports, December 2016, Portland Press Ltd.

    Ba Hieu Tran

  6. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction

    Article • Bioscience Reports, June 2015, Portland Press Ltd.

    Ba Hieu Tran

  7. P11 Determination pharmacokinetic properties and cardioprotective effects of a novel hydrogen sulfide agent – Controlled release formulation of S-propargyl-cysteine on acute myocardial infarction rats

    Article • Nitric Oxide, May 2014, Elsevier

    Ba Hieu Tran

  8. Cardioprotective Effects of a Novel Hydrogen Sulfide Agent–Controlled Release Formulation of S-Propargyl-Cysteine on Heart Failure Rats and Molecular Mechanisms

    Article • PLOS One, July 2013, PLOS

    Ba Hieu Tran